Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ding-Chao Rong

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Orthopaedics|December 4, 2025
Prognostic model for osteosarcoma: RNA diagnostics, tumor microenvironment and immunotherapy responseDing-Chao Rong, Xu Rong, Yuan-Shen Chen, et al.
Molecular Biomedicine|October 30, 2025
ROS homeostasis in cell fate, pathophysiology, and therapeutic interventionsYuan-Shen Chen, Hui-Xiang Tian, Ding-Chao Rong, et al.
Molecular and Cellular Biochemistry|October 18, 2023
The romantic history of signaling pathway discovery in cell death: an updated reviewLei-Yun Wang, Xing-Jian Liu, Qiu-Qi Li, et al.
Medcomm|September 17, 2024
Anoikis in cell fate, physiopathology, and therapeutic interventionsJie Mei, Xue-Yao Jiang, Hui-Xiang Tian, et al.
Journal of Advanced Research|May 19, 2025
Heme oxygenase 1 (HO-1) is a drug target for reversing cisplatin resistance in non-small cell lung cancerJie Mei, Hui-Xiang Tian, Xiao-Ye Zhang, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Orthopaedics|December 4, 2025
Prognostic model for osteosarcoma: RNA diagnostics, tumor microenvironment and immunotherapy responseDing-Chao Rong, Xu Rong, Yuan-Shen Chen, et al.
Molecular Biomedicine|October 30, 2025
ROS homeostasis in cell fate, pathophysiology, and therapeutic interventionsYuan-Shen Chen, Hui-Xiang Tian, Ding-Chao Rong, et al.
Molecular and Cellular Biochemistry|October 18, 2023
The romantic history of signaling pathway discovery in cell death: an updated reviewLei-Yun Wang, Xing-Jian Liu, Qiu-Qi Li, et al.
Medcomm|September 17, 2024
Anoikis in cell fate, physiopathology, and therapeutic interventionsJie Mei, Xue-Yao Jiang, Hui-Xiang Tian, et al.
Journal of Advanced Research|May 19, 2025
Heme oxygenase 1 (HO-1) is a drug target for reversing cisplatin resistance in non-small cell lung cancerJie Mei, Hui-Xiang Tian, Xiao-Ye Zhang, et al.
Pageof 1